EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Peptides And Non Peptides Of Oncologic And Neuroendocrine Relevance From Basic To Clinical Research 1st Edition A V Schally Auth

Name: Peptides And Non Peptides Of Oncologic And Neuroendocrine Relevance From Basic To Clinical Research 1st Edition A V Schally Auth
SKU: BELL-4475834
Price: 31.00 USD
Availability: InStock
Rating: 4.7 (26 reviews)

SKU: BELL-4475834

$ 31.00 ~~$ 45.00~~ (-31%)

4.7

26 reviews

Peptides And Non Peptides Of Oncologic And Neuroendocrine Relevance From Basic To Clinical Research 1st Edition A V Schally Auth instant download after payment.

Publisher: Springer-Verlag Mailand

File Extension: PDF

File size: 8.87 MB

Pages: 197

Author: A. V. Schally (auth.), Eugenio E. Müller (eds.)

ISBN: 9788847020856, 9788847021709, 8847020859, 8847021707

Language: English

Year: 2003

Edition: 1

Product desciption

Peptides And Non Peptides Of Oncologic And Neuroendocrine Relevance From Basic To Clinical Research 1st Edition A V Schally Auth by A. V. Schally (auth.), Eugenio E. Müller (eds.) 9788847020856, 9788847021709, 8847020859, 8847021707 instant download after payment.

The book describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds